| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |